Veradigm Inc (MDRX)
OTCMKTS: MDRX · Delayed Price · USD
9.50
0.00 (0.00%)
Jul 8, 2024, 1:07 PM EDT - Market open

Veradigm Market Cap

Veradigm has a market cap or net worth of $1.02 billion as of July 8, 2024. Its market cap has decreased by -46.12% in one year.

Market Cap
1.02B
Enterprise Value
n/a
1-Year Change
-46.12%
Ranking
n/a
Category
Stock Price
$9.50

Market Cap Chart

Since July 26, 1999, Veradigm's market cap has increased from $319.80M to $1.02B, an increase of 219.76%. That is a compound annual growth rate of 4.84%.

History

DateMarket Cap% Change
Feb 28, 2024744.10M-35.08%
Dec 29, 20231.15B-40.53%
Dec 30, 20221.93B-14.78%
Dec 31, 20212.26B-0.87%
Dec 31, 20202.28B43.15%
Dec 31, 20191.59B-5.38%
Dec 31, 20181.68B-35.94%
Dec 29, 20172.63B39.11%
Dec 30, 20161.89B-34.99%
Dec 31, 20152.91B26.29%
Dec 31, 20142.30B-16.56%
Dec 31, 20132.76B70.53%
Dec 31, 20121.62B-54.94%
Dec 30, 20113.59B0.04%
Dec 31, 20103.59B22.25%
Dec 31, 20092.94B102.85%
Dec 31, 20081.45B31.26%
Dec 31, 20071.10B-23.88%
Dec 29, 20061.45B156.25%
Dec 30, 2005565.30M38.05%
Dec 31, 2004409.50M97.73%
Dec 31, 2003207.10M125.60%
Dec 31, 200291.80M-25.43%
Dec 31, 2001123.10M-54.22%
Dec 29, 2000268.90M-74.69%
View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 869.21B
Novo Nordisk 635.31B
UnitedHealth Group 449.16B
Johnson & Johnson 352.53B
Merck & Co. 320.27B
AbbVie 295.34B
AstraZeneca 239.80B
Novartis AG 211.55B
Market Cap Rankings